Richard Schlenker
Analyst · Tim McHugh with William Blair
Thanks, Paul. For the third quarter, total revenues increased 11% to $73.3 million, from $66 million in 2011. Revenues before reimbursements, or net revenues as I will refer to them from here on, increased 9% to $66.7 million in the quarter as compared to $61.4 million in the prior year period. Net income for the third quarter increased 17% to $10.2 million or $0.72 per diluted share as compared to $8.7 million or $0.60 per diluted share in the prior year period.
EBITDA in the third quarter increased 13% to $17.4 million as compared to $15.4 million in the same period last year. For the first 9 months of 2012, total revenues increased 7% to $219.7 million. Net revenues increased 8% to $201.5 million. Net income for the first 9 months of 2012 improved 15% to $28.8 million or $2.01 per diluted share. EBITDA in the first 9 months of the year improved 13% to $50.5 million.
Overall, we are pleased with our third quarter and year-to-date performance. This performance sets up for a strong 2012, which is especially noteworthy considering the high hit -- hurdle we established in 2011.
Turning back to the details of our third quarter performance. Net revenues from our defense technology development business were $4.4 million as compared to $3.6 million in the same quarter last year. We saw an increase in activities from our U.K. ground penetrating radar program, while we worked on completing the current round of development of U.S. GPR. Additionally, we continued to support the Rapid Equipping Force's new mobile labs in Afghanistan.
Net revenues from product sales in the third quarter of 2012 were $48,000 as compared to $253,000 in the same period last year. We now expect net revenues from product sales to be approximately $2 million in the fourth quarter. We have secured both of the surveillance system product contract we discussed last quarter.
As Paul discussed, utilization in the third quarter was strong at 74% as compared to 72% in the same quarter last year. This was driven by 7% increase in billable hours, totaling 267,000. We expect our utilization in the fourth quarter to step down to 68% to 70%, as there are more holidays and vacations in the period, as well as the impact of a gradual step down in some major assignments.
Growth in FTEs was 4.5% to 694, from 664 in the same period last year. We expect FTEs to grow 1% to 1.5% sequentially in the fourth quarter. During the third quarter of 2012, we realized an average billing rate increase of approximately 2.5% over the prior year period. We expect to realize the billing rate increase of about the same for the full year. The percentages I will reference hereafter are on a percentage of net revenue basis.
EBITDA margin for the third quarter improved 90 basis points to 26.1%, from 25.2% in the same period last year, as a result of strong utilization. For the third quarter, compensation expense, after adjusting for gains and losses and deferred compensation, increased 8% to $42.6 million, as compared to $36.1 million last year. This increase is the result of headcount growth and annual compensation increases, which took effect in April.
Included in total compensation in the third quarter is a gain in deferred compensation of $1.1 million, as compared to a loss of $2.5 million in the same quarter last year. As a reminder, deferred compensation, gains and losses are offset in miscellaneous income, and therefore, have no effect on the bottom line.
As a component of compensation, stock-based compensation expense for the third quarter increased to $2.7 million as compared to $2.3 million in the same period in a year ago. For the full year, we expect stock-based compensation to be approximately $12.5 million.
Other operating expenses for the third quarter were about flat with the prior year at $5.9 million. As a component of other operating expense, depreciation was $1.1 million. We expect other operating expenses to be in the range of $6 million to $6.5 million in the fourth quarter.
G&A expenses in the third quarter increased to $3.5 million from $3 million a year ago. This increase was a result of a firm-wide managers meeting that was held at the end of the third quarter of 2012. We expect G&A expenses in the fourth quarter to be $3.8 million to $4 million.
Interest income in the third quarter was $80,000. Our tax rate for the third quarter of 2012 was 37.4%, down from 39.3% in the same period last year due to a non-reoccurring benefit of about $420,000. For 2012, we now expect our tax rate to be approximately 39.3%. As we look forward to 2013, we estimate our tax rate to be at 40.3%.
Turning to the balance sheet. Cash, cash equivalents and short-term investments increased slightly over the prior quarter to $110 million. During the quarter, we repurchased about $1 million of common stock, bringing our year-to-date total to $19.4 million. We still have $25 million available under our current authorization for stock repurchases.
Capital expenditures for the third quarter were $1.5 million. This was higher in the quarter because we had a couple of tenant improvement projects that we were paying for. DSOs were 103 days at the end of the quarter. This is higher than usual, due to a couple of defense technology development contracts that were structured to bill near the completion of the project and as a result, remain outstanding at the close of the quarter.
Given our strong year-to-date performance, we are again increasing our fiscal year 2012 outlook. We now expect growth in revenues before reimbursements to be in the high single digits and full year EBITDA margin to increase between 80 and 100 basis points over the prior year. Our growth expectations are particularly significant given the strong 2011 comparable.
Now I will turn the call back to Paul for concluding remarks.